Post-Covid Syndrome- An Overlook
Journal: International Journal of PharmaO2 (IJPO) (Vol.2, No. 5)Publication Date: 2020-09-04
Authors : Vilas A. Patil;
Page : 0311-0314
Keywords : COVID-19 Post-Covid Syndrome FDA.;
Abstract
After recovering from the initial infection from COVID-19 though out world some people has been ambushed by a baffling array of symptoms, including extreme fatigue, a foggy brain, a raised heartbeat and diarrhea. Recent analysis by the Covid Symptom Study suggested that as many as one in 10 people with Covid-19 have been sick for more than three weeks after symptoms first emerge. Corona virus that causes Covid-19 is a very different virus than influenza, so its long-term consequences are likely going to reflect. Treatment is mainly focused on reassurance, self-care, and symptomatic control. There are currently no FDA-approved treatments specifically for this condition.
Other Latest Articles
- The Decentralization of the Administration of Basic Education to Councils and its Effectiveness on Educational Supply
- Colorimetric Determination of Stability Constant of Trimethoprim Cu II Complex at Different Temperatures by Continuous Variation Method
- Towards an Effective University E Learning
- Assess the Knowledge of Breast Self Examination Due to Cancer, and to Find Out Relationship between Socio Demographic Variables
- Study of Effectiveness of Various Promotional Strategies used by Honda
Last modified: 2020-09-08 16:08:58